-
Health todayObesity, diabetes and GLP-1 new
Adults with diabetes lost more muscle after starting a GLP-1 drug
In the German National Cohort, adults with diabetes who started a GLP-1 drug lost 2.75 percentage points more skeletal muscle volume than matched adults who did not.
Preprint · not peer-reviewed -
Data, models and systemsForecasts and their record new
New Zealand had few excess deaths through the pandemic and its aftermath
A model fitted to 22 years of monthly death counts estimates that New Zealand had few excess deaths during the pandemic, and was back to pre-pandemic mortality by 2025.
Peer-reviewed -
Health todayHeart and stroke new
The largest treatment gaps are not where cardiovascular risk could fall most
The populations with the largest treatment gaps were not those where treating currently untreated people would achieve the greatest absolute reduction in cardiovascular risk.
Peer-reviewed -
Tomorrow's worldA changing climate refines
Landscape fire smoke accounted for 1.9% of deaths and $994.5 billion in losses
Across 1366 communities in ten countries and territories over 2000-19, smoke from landscape fires was estimated to account for 906,869 deaths and $994.5 billion in mortality-related economic losses.
Peer-reviewed -
Tomorrow's worldA changing climate confirms
Residential greenspace linked to lower respiratory deaths from air pollution
A review of 14 cohort studies, mostly European, found residential greenspace associated with lower air-pollution-related respiratory mortality, through cleaner local air rather than reduced personal susceptibility to pollution.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
Diabetes was more common in older US influenza deaths than in COVID-19 deaths
Among US inpatients aged over 65 who died, 46.6% of those dying of COVID-19 had diabetes, as compared to 63.1% of those dying of influenza.
Peer-reviewed -
Health todayCancer refines
Pancreatic cancer risk on GLP-1 drugs depends on the diabetes drug compared
Pancreatic cancer was less common in GLP-1 starters than in starters of four other diabetes classes, while against insulin the paper reports a lower hazard but a higher absolute risk.
Peer-reviewed -
Health todayCancer confirms
Colorectal screening from 45 still misses cancers diagnosed before that age
A review of 45 studies found detection of colorectal neoplasia rises with age under 50, but a considerable share of cases arise before 45 and outside screening eligibility.
Peer-reviewed -
Health todayHeart and stroke confirms
Cardiogenic shock deaths fall as hospital cardiac capability rises in US admissions
Across an estimated 1.18 million US admissions for cardiogenic shock, crude in-hospital mortality fell from 64.4% at hospitals without percutaneous coronary intervention to 36.5% at heart transplant centres.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 confirms
GLP-1 drugs cut weight by 6.7 kg in patients taking antipsychotics
A meta-analysis of eight randomised trials in 664 patients taking antipsychotics found that GLP-1 receptor agonists reduced body weight by 6.74 kg, alongside more nausea, vomiting and constipation.
Peer-reviewed -
Health todayCancer new
Second primary lung cancers in Sweden have risen steadily since 1980
The Swedish national cancer registry identified 853 second primary lung cancers from 1961 to 2021, arising at 3.59 times the rate at which first lung cancers arise in the population.
Peer-reviewed -
Health todayCancer confirms
Scotland's lung screening pilot drew a 23.8% response to its invitations
Inviting 2801 people with a smoking history recorded in Scottish primary care records to a lung health check produced a response rate of 23.8%, lower in more deprived areas.
Peer-reviewed
